好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Specialties and Clinical Roles of Those Performing Informed Consent for Endovascular Thrombectomy: A Survey of Providers
Practice, Policy, and Ethics
P1 - Poster Session 1 (11:45 AM-12:45 PM)
1-013
Investigate the medical specialties and clinical roles of individuals who obtain informed consent (IC) for endovascular thrombectomy (EVT), aiming to provide insights for enhancing the process in contemporary stroke care.
IC plays a central role in medical care and research. Practices for EVT in acute stroke are not well elucidated, particularly with regard to who obtains IC.
A survey was conducted from July to December 2023 among providers involved in acute stroke care. Utilizing Qualtrics, a structured questionnaire was disseminated through various national and international platforms including the 好色先生 and StrokeNet. 

Among 168 participants, 71% were staff physicians, 70% practiced in the United States (US), and 70% were based at academic centers. The most common medical specialties obtaining EVT IC were neurology (77%), followed by neurosurgery (41%), radiology (30%) and emergency medicine (10%). Staff physician (61%) was the most common clinical role involved, followed by fellows (43%), residents (48%), and advanced practice providers (APP, 36%). Non-US institutions were more likely to utilize a provider from neurology alone (50% vs. 31%, p=0.016) and staff physicians (76% vs. 54%, p=0.008), while US institutions were more likely to utilize providers from neurosurgery (51% vs. 18%, p<0.001), APPs (43 vs. 18%, p=0.002) and residents (56% vs. 28%, p=0.001). Non-academic institutions more frequently used emergency medicine providers (25% vs. 5%, p<0.001) and APPs (50% vs. 31%, p=0.031), while academic institutions commonly utilized neurosurgery providers (48% vs. 18%, p=0.001), residents (59% vs. 13%, p<0.001) and fellows (52% vs. 18%, p<0.001).

This study highlights the diverse medical specialties and clinical roles of persons obtaining IC for EVT. These variations likely reflect provider availability and clinical culture in different settings. Future efforts to optimize the IC process should be multi-disciplinary, with standardized content that addresses provider diversity.

Authors/Disclosures
Amir A. Mbonde, MD (Mayo Clinic Arizona)
PRESENTER
Dr. Mbonde has nothing to disclose.
Ali A. Alsarah, MD (University of New Mexico Hospital- Department of Neurology) Dr. Alsarah has nothing to disclose.
Bart Demaerschalk, MD, MSc, FRCPC, FAAN (Mayo Clinic) Dr. Demaerschalk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Demaerschalk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. Dr. Demaerschalk has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for The Neurologist . The institution of Dr. Demaerschalk has received research support from NICHD.
Adam Dmytriw (Massachusetts General Hospital) Adam Dmytriw has nothing to disclose.
Quentin Moyer (Massachussetts General Hospital) No disclosure on file
Joshua A. Hirsch, MD Dr. Hirsch has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medtronic. Dr. Hirsch has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Relievant. Dr. Hirsch has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Hirsch has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerenovus. Dr. Hirsch has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Balt. Dr. Hirsch has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Rapid Medical.
Aneesh B. Singhal, MD, FAAN (Massachusetts General Hospital) An immediate family member of Dr. Singhal has received personal compensation for serving as an employee of Biogen. Dr. Singhal has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Medicolegal Firms. Dr. Singhal has received research support from NIH-NINDS. Dr. Singhal has received publishing royalties from a publication relating to health care. Dr. Singhal has received publishing royalties from a publication relating to health care. Dr. Singhal has received personal compensation in the range of $500-$4,999 for serving as a Honorarium (好色先生) with Biogen.
Thabele M. Leslie-Mazwi, MD Dr. Leslie-Mazwi has a non-compensated relationship as a Board Member with American Brain Foundation that is relevant to AAN interests or activities. Dr. Leslie-Mazwi has a non-compensated relationship as a Council Member with American Heart Association/American Stroke Association that is relevant to AAN interests or activities.
Natalia S. Rost, MD, MPH, FAAN, FAHA (Massachusetts General Hospital) Dr. Rost has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for 好色先生. Dr. Rost has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stroke - AHA/ASA Journal. The institution of Dr. Rost has received research support from NIH. Dr. Rost has received publishing royalties from a publication relating to health care.
Aman Patel Aman Patel has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Microvention. Aman Patel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Stryker. Aman Patel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Aman Patel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Penumbra.
Michael Young, MD (Massachusetts General Hospital, Brigham, Harvard) The institution of Dr. Young has received research support from NIH/NINDS. The institution of Dr. Young has received research support from Department of Defense. The institution of Dr. Young has received research support from Chen Institute.
Robert W. Regenhardt, MD, PhD Dr. Regenhardt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genomadix. Dr. Regenhardt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Rapid Medical. Dr. Regenhardt has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Johnson and Bell Trial Lawyers. Dr. Regenhardt has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Buckley, Theroux, Kline, & Cooley Trial Lawyers. The institution of Dr. Regenhardt has received research support from National Institutes of Health. The institution of Dr. Regenhardt has received research support from Society of Vascular and Interventional Neurology. The institution of Dr. Regenhardt has received research support from Heitman Foundation.